This intensive 1-day workshop at MIT will help you understand the expected impact of the therapy pipeline and learn to leverage tools to help determine how your plan could be affected.
This second in a series of workshops from the FoCUS Consortium is designed to share research and solutions to the challenge of paying for high cost, durable and curative therapies. You will leave understanding the estimated clinical trial pipeline of these types of therapies and their potential impact on the healthcare system. Further, you will learn the new frameworks available for implementing cutting edge financing agreements and hear from those who are breaking new ground with their unique methods of working to balance financing risks with these curative therapies and their potential to end disease. Bringing together a holistic set of insights from patient, payer, provider and developer experiences, this workshop will provide helpful tools that you can use within your organization as you plan for the future.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
